Floatz logo

NEPENTHE

Cancer of Cervix

Rabin Medical CenterSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Cancer of Cervix cohort.

Asset / SponsorPhaseRating
Hepatitis B Virus Vaccine
Eunice Dube
Phase 4BB
Gardasil 9 Vaccine
Eunice Dube
Phase 4BB
METAMIZOLE
Rabin Medical Center
Phase 3B
DEXKETOPROFEN
Rabin Medical Center
Phase 3B
Dpx-E7 Vaccine
Dana-Farber Cancer Institute
Phase 1/2CCC
Infigratinib
The University of Texas Health Science Center at San Antonio
Phase 1CC

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →